NaturalPlastics1

Cardia Bioplastics is pleased to announce that is has established a 100% subsidiary “CO2STARCH Pty Ltd”. This vehicle will be used to commercialise the company’s patented novel CO?polymer-starch blending technology.

CO2STARCH Pty Ltd will hold all the intellectual property and patents and will serve as the platform for the development and commercialization of a family of CO2based polymers.

Cardia launched the world's first CO2+Starch biodegradable carrier bag (made using CO2 emissions) in October 2010 and has since received interest in the technology from several major international organizations including petrochemical companies. The breakthrough technology allows PPC (polypropylene carbonate) to be blended
with starch.

In simple terms, CO2 emissions are captured and used as a substitute for oil and then further blended with starch as an additional substitute for oil to create a renewable and sustainable bioplastics that rely less on fossil fuels.

Cardia Bioplastics has appointed Brazil's leading sustainable packaging company as its exclusive distributor for Brazil.

Eco Ventures Do Brasil (Eco Ventures), will distribute Cardia's portfolio of Biohybrid^TM and compostable resins derived from sustainable resources, in Brazil.

The exclusive distribution agreement enables Eco Ventures, a subsidiary of World Eco Ventures, to offer customers the comprehensive range of Cardia Bioplastics sustainable resins to the Brazilian packaging and plastic products industries.

Eco Ventures Chief Operating Officer Joao Paulo Mignot said the Cardia Bioplastics range would provide sustainable polymer choices for customers.

"As the ‘green space' grows, we have looked for a leading bioplastics supplier with a full portfolio of sustainable options. The Cardia Bioplastics range of products allows our customers a choice," he said.

"Depending on their specific product and sustainability needs, customers can choose from Cardia Biohybrid^TM or Cardia certified compostable resins."

"These materials can be converted with standard processing equipment to a broad range of packaging and plastics products," said Joao Paulo.

Cardia Bioplastics Managing Director Dr Frank Glatz said the Eco Ventures agreement further extended the company's global distributor roll out.

"We are delighted to have this partnership with Eco Ventures do Brasil Ltd, the leading sustainable packaging and plastics products distributor in the Brazilian market."

"This is all part of our global expansion strategy."
"Growth for the sustainable resins market is driven by changing public attitudes and corresponding regulatory requirements. Another driver for sustainable packaging is the growing certainty that reduction in use of fossil fuels; is coming closer."

"Packaging and plastics businesses know that eventually higher petroleum prices will erode their competitiveness and their profit margins, and they want packaging and bioplastics products solutions based on sustainable resources," Dr Glatz said.

Cardia Bioplastics and Eco Ventures do Brasil are benefiting from the trend towards sustainable packaging with products used in a broad range of packaging applications, including flexible film, injection moulding, blow moulding, foam, extrusion and coating applications.

Customers will have the choice of using sustainable Cardia BiohybridTM technology or Cardia's Compostable technology for their packaging or plastic products applications.

Cardia Biohybrid^TM proprietary technology combines renewable thermoplastics with polyolefin material to reduce dependence on finite oil resources and to reduce carbon footprint. Cardia Compostable resins are high performance packaging materials certified to international compostable packaging standards like USA ASTM 6400 and Europe's EN13432:2000.

About Cardia Bioplastics
Cardia Bioplastics Limited (ASX CODE: CNN), through its 100% owned subsidiary Cardia Bioplastics Australia Pty Ltd, develops, manufactures and markets sustainable resins and finished products derived from renewable resources for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. Established in Australia in 2002 as Biograde, the company Headquarters and Global Applications Development Centre is in Melbourne, Australia. The Product Development Centre and manufacturing plant is in Nanjing, China. There are Cardia Bioplastics offices in the Americas, Europe and China, and a network of leading distributors across Australia, the Americas, Asia and Europe. Visit www.cardiabioplastics.com

About Eco Ventures do Brasil
Eco Ventures do Brasil is Brazil's leading distributor of sustainable packaging products. Eco Ventures focuses on distributing Biohybrid^TM and certified compostable products packaging products made with less oil and a better carbon footprint. Eco Ventures has a high reputation, strong technical expertise and sales resources in the Brazilian market place. Visit www.ecoventuresbrasil.com

Cardia Bioplastics has received European and USA food contact certification for injection moulded products made from its Cardia Biohybrid™ materials. This follows the food contact approval received for its multilayer flexible film products in 2009.

Cardia Biohybrid^TM food contact rigid packaging products are certified compliant to Europe's Regulation (EC) 1935/2004 and USA's FDA CFR 21 for materials and articles intended to come into contact with food.

The breakthrough significantly expands Cardia Bioplastics market opportunities in food packaging applications. Cardia Bioplastics customers can now offer every day food packaging items, such as containers, closures, tubes, tubs and bottles, using Cardia Biohybrid^TM technology.

Cardia already has rigid food packaging products development agreements with several companies and is awaiting commercial outcomes. Cardia Bioplastics Managing Director Dr Frank Glatz said achieving European and USA food contact certification for injection moulded products is an important milestone for Cardia Bioplastics.

"Our ability to offer both rigid and flexible film packaging products, with high performance, strong environmental profile, food contact compliance and cost effectiveness, makes Cardia Biohybrid^TM technology a compelling package for the global food industry," said Frank Glatz.

Reduce oil consumption and carbon footprint

Cardia Biohybrid^TM proprietary technology combines renewable thermoplastics with polyolefin material to reduce dependence on finite oil resources and to reduce carbon footprint. Cardia Bioplastics is expanding its extensive patent portfolio with new lodgements to protect this innovative technology.

"This development enables customers to move confidently into more sustainable packaging solutions. Cardia Biohybrid^TM injection moulded products and multilayer films offer food marketers packaging solutions with a real competitive edge for their products," said Frank Glatz.

"Cardia Bioplastics now has technologies covering the packaging market comprehensively. The range starts with commodity packaging and extends to the high end food packaging industry. Our sustainable packaging applications now include flexible film, injection moulding, blow moulding, foam, and extrusion and coating applications.

"We also offer customers the choice of Cardia Bioplastics internationally certified Compostable technology for their packaging or plastic products," he said.

Source: http://www.cardiabioplastics.com

Cardia Bioplastics now seeks international commercial partner to advance world first technology

Melbourne packaging technology company Cardia Bioplastics Limited (ASX: CNN) has developed a world first biodegradable plastic bag created from a blend of CO2
(carbon dioxide) emissions and starch.

Chairman Pat Volpe said the company has successfully completed a first production run of the revolutionary carrier bags, known as CO2S^TM - or, carbon dioxide plus a starch based renewable resource.

"This is the first time CO2 emissions have been transformed in this way, and the development has the potential to revolutionise the production of bioplastics around the globe," he said.

Pollutant CO2 emissions are captured prior to being released into the atmosphere.
This pollutant is then transformed into a polypropylene carbonate (PPC) polymer and blended with a renewable resource (starch), using the company's new technology, to produce the Cardia Bioplastics CO2S^TM resin. This product is then used to produce a completely biodegradable carrier bag.

Pat Volpe said this revolutionary development promises to offer packaging alternatives globally, with the company now in discussion with several parties interested in the technology.

"Our new patent pending blending technology used to manufacture CO2S^TM compostable product will complement the existing Cardia Bioplastics portfolio." Pat Volpe said.

"We are delighted to be at the cutting edge of green technology by developing a new generation of bioplastics films for carrier bags and other products that is able to transform a problematic waste pollutant into an environmentally friendly alternative product," he said.

Cardia Bioplastics now plans to perfect the new CO2S^TM technology by increasing the PPC content and the renewable resource component so that up to 60% less virgin oil will be used, when compared to currently marketed biodegradable oil based products.

Cardia Bioplastics will also aim to achieve international compostability accreditation standards for CO2S^TM. Pat Volpe said manufacturing can easily be scaled up to meet commercial volumes with the aim to provide CO2S^TM bags at prices below current compostable carrier bags.

"We are now ready to commercialise this innovative technology and are searching for a suitable international partner with oil or gas wells, or refineries producing CO2 emissions. We are getting close in our negotiations and the market will be informed when current discussions materialise into a support agreement," he said.

Source: http://www.cardiabioplastics.com

Australian global sustainable packaging developer Cardia Bioplastics Limited (ASX: CNN) has signed an international supply and licensing agreement, on confidential terms, with a United States packaging supplier

Cardia will manufacture and supply a range of its sustainable packaging products under a joint branding license. Based on the forward projections of the American packaging company, Cardia is expected to realise revenue of at least AUD$1.8 million per annum.

Cardia Managing Director, Dr Glatz said the agreement was signed following performance testing of the Cardia Compostable product technology, which met stringent USA compostability standard ASTM6400. The Supply and License Agreement also provides for product co-branding, and this co-branding will further enhance Cardia Bioplastics' profile amongst American consumers.

"It is Cardia's first substantial contract in the large American packaging market and comes within weeks of signing several supply agreements in both China and Australia," he said.

Dr Frank Glatz said the US contract was underpinned by strengthening demand for bioplastics in North America, with business and consumers demanding ‘greener' alternatives in all kinds of packaging products.

He said several cities, including San Francisco and Seattle, had legislated to ban the use of non-compostable carrier bags and several state governments, including California, Texas and Minnesota were also expected to follow suit.

"US President Barack Obama has also announced a new green plan to use less oil and is committed to seeking more renewable and sustainable options," Dr Glatz said.

"The Cardia Bioplastics range of renewable Biohybrid^TM and certified compostable products using Cardia's proprietary technology has created significant interest in the USA."

Cardia has established local technical support and the logistical infrastructure to ensure effective supply capability into the USA from Cardia's modern manufacturing plant in Nanjing, China.

"We are ready to expand into the USA and this supply agreement is further endorsement that our Bioplastics products are now being internationally sourced by customers." Dr Glatz said.

Source: http://www.cardiabioplastics.com/